Emeren Group, Ltd.
SOL · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -2.47 | -0.12 | 0.01 |
| FCF Yield | 0.00% | 0.15% | -5.64% | 5.25% |
| EV / EBITDA | 6.09 | -5.77 | 22.85 | -10.37 |
| Quality | ||||
| ROIC | -27.13% | -8.67% | -0.67% | -0.99% |
| Gross Margin | 60.83% | 51.76% | 39.35% | 13.86% |
| Cash Conversion Ratio | -101.96 | -1.52 | -1.23 | -0.87 |
| Growth | ||||
| Revenue 3-Year CAGR | -4.33% | -9.16% | 9.25% | 17.81% |
| Free Cash Flow Growth | -1,454.21% | 103.08% | -183.18% | 155.90% |
| Safety | ||||
| Net Debt / EBITDA | 6.09 | -1.54 | 5.42 | -1.18 |
| Interest Coverage | -4.38 | -45.24 | -10.81 | -10.65 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 82.45 |
| Cash Conversion Cycle | -69.40 | 432.48 | 609.61 | 148.66 |